Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
23.21
-0.67 (-2.81%)
At close: Sep 12, 2025, 4:00 PM EDT
23.10
-0.11 (-0.47%)
After-hours: Sep 12, 2025, 6:30 PM EDT
Indivior Market Cap
Indivior has a market cap or net worth of $2.90 billion as of September 12, 2025. Its market cap has increased by 72.52% in one year.
Market Cap
2.90B
Enterprise Value
2.75B
1-Year Change
72.52%
Ranking
Category
Stock Price
$23.21
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $2.90B, an increase of 89.20%. That is a compound annual growth rate of 6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 2.90B | 86.43% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |